Journal profile · Oncogenes-CELL BIOLOGY

Oncotarget

ISSN 1949-2553 · Impact Journals LLC · United States · Monthly · Founded 2009

Oncotarget: fully open access; review 4–8 weeks (community reports); community-reported acceptance: fairly hard; 132 articles in 2025; indexed in Scopus.

Impact factor—No published value
CAS zone—Not in the CAS Journal Ranking
CiteScore quartileQ2Oncology · rank 141/428
Review time4–8 weeksCommunity average
APC—No source gives fee information
AcceptanceFairly hardCommunity average
Articles per year1322025 · OpenAlex count

Scope

Aims, scope and focus

Oncotarget is published by Impact Journals LLC. By OpenAlex counts of its recent articles, its largest topics are Cancer-related molecular mechanisms research, MicroRNA in disease regulation and Cancer Cells and Metastasis, together about 23.7% of its articles. Its main subfields are Cancer Research and Oncology. (generated from OpenAlex topic counts and CAS ranking data)

Information not localized

Source: LetPub

Research area (LetPub): Oncogenes-CELL BIOLOGY

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology8.2%
  2. MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology7.9%
  3. Cancer Cells and MetastasisMedicine7.6%
  4. Cancer-related Molecular PathwaysMedicine5.1%
  5. Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology4.6%
  6. Glioma Diagnosis and TreatmentMedicine4.5%
  7. Cancer Immunotherapy and BiomarkersMedicine4.1%
  8. Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology4.1%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

CiteScore quartiles (Scopus, June 2026 release)

SubjectQuartileRankPercentile
OncologyQ2141/428—

Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub

Database indexing

ScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

CiteScore 2026-06
5.4LetPub ·
SJR 2026-06
0.83LetPub ·
SNIP 2026-06
0.79LetPub ·
h-index
91LetPub ·
h-index
222OpenAlex ·
i10-index
22,008OpenAlex ·
2-year mean citedness
2.3OpenAlex ·
Share of gold OA articles
0%LetPub ·

Volume

Articles per year
6,625LetPub ·

Articles by year OpenAlex count · 27,624 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026949445,868
202513213270,991
202412712782,919
202318018091,607
2022149149106,293
2021296296126,177

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
4–8 weeksLetPub ·
Average acceptance (community reports)
Fairly hardLetPub ·

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessOpenAlex

Every article is open access; authors usually pay an article processing charge (APC).

No source has fee information yet; check the journal's website.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Impact Journals LLC
Country or region
United States
Frequency
Monthly
Founded
2009
ISSN
1949-2553
Official links

FAQ

Frequently asked questions about Oncotarget

How long does peer review take at Oncotarget?

Authors report an average review time of 4–8 weeks; the community-reported acceptance is “Fairly hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Oncotarget?

According to LetPub and DOAJ records, Oncotarget is indexed in Scopus.

Is Oncotarget open access, and what is the APC?

Oncotarget is a fully open-access journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .